Patents by Inventor Norberto Guzman

Norberto Guzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931741
    Abstract: Micro-valve system includes two or more superimposed tubes and a pressing device for fluid control in miniaturized capillary connections. The micro-valve system and method of fabrication can be tailored to the requirements of a wide range of applications; composition, sturdiness and thickness of plastic tubes; and capable of been adapted to the resilient of mechanical pressure and the passing and transport of fluid types.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: March 19, 2024
    Assignee: Princeton Biochemicals, Inc
    Inventors: Norberto Guzman, Daniel E. Guzman
  • Publication number: 20230400432
    Abstract: A diagnostic and prognostic method and system for sequentially analyzing in a biological fluid or tissue extract the presence of an antigenic infectious agent, infectious organism or its toxic product; an antibody response to the antigenic infectious agent, infectious organism or its toxic product; one or more biomarkers formed during infection in response to a communicable disease; and one or more biomarkers to assess the severity of the disease and to monitor the effectiveness of drug therapy or vaccination.
    Type: Application
    Filed: August 24, 2023
    Publication date: December 14, 2023
    Inventor: Norberto A. Guzman
  • Patent number: 11740204
    Abstract: A diagnostic and prognostic method and system for sequentially analyzing in a biological fluid or tissue extract the presence of an antigenic infectious agent, infectious organism or its toxic product; an antibody response to the antigenic infectious agent, infectious organism or its toxic product; one or more biomarkers formed during infection in response to a communicable disease; and one or more biomarkers to assess the severity of the disease and to monitor the effectiveness of drug therapy or vaccination.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: August 29, 2023
    Assignee: PRINCETON BIOCHEMICALS INC
    Inventor: Norberto A. Guzman
  • Publication number: 20220170885
    Abstract: A diagnostic and prognostic method and system for sequentially analyzing in a biological fluid or tissue extract the presence of an antigenic infectious agent, infectious organism or its toxic product; an antibody response to the antigenic infectious agent, infectious organism or its toxic product; one or more biomarkers formed during infection in response to a communicable disease; and one or more biomarkers to assess the severity of the disease and to monitor the effectiveness of drug therapy or vaccination.
    Type: Application
    Filed: February 16, 2022
    Publication date: June 2, 2022
    Inventor: NORBERTO A. GUZMAN
  • Patent number: 11287396
    Abstract: A diagnostic and prognostic method and system for sequentially analyzing in a biological fluid or tissue extract the presence of an antigenic infectious agent, infectious organism or its toxic product; an antibody response to the antigenic infectious agent, infectious organism or its toxic product; one or more biomarkers formed during infection in response to a communicable disease; and one or more biomarkers to assess the severity of the disease and to monitor the effectiveness of drug therapy or vaccination.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: March 29, 2022
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventor: Norberto A. Guzman
  • Patent number: 11262330
    Abstract: An electrophoresis apparatus is generally disclosed for sequentially analyzing a single sample or multiple samples having one or more analytes in high or low concentrations. The apparatus comprises a relatively large-bore transport capillary which intersects with a plurality of small-bore separation capillaries and includes a valve system. Analyte concentrators, having antibody-specific (or related affinity) chemistries, are stationed at the respective intersections of the transport capillary and separation capillaries to bind one or more analytes of interest. The apparatus allows the performance of two or more dimensions for the optimal separation of analytes. The apparatus may also include a plurality of valves surrounding each of the analyte concentrators to localize each of the concentrators to improve the binding of one or more analytes of interest.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: March 1, 2022
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventor: Norberto A. Guzman
  • Patent number: 11198118
    Abstract: The present invention relates to an immunoaffinity device for capturing, isolating and purifying one or more analytes of interest present at high or low concentration in simple or complex matrices. The device is designed as an integrated modular unit that includes one or more analyte concentrator-microreactor devices anchored into a T-shaped support box, which is built-in or connected to a interchangeable cartridge-cassette of a capillary electrophoresis or liquid chromatography apparatus for the isolation, enrichment, derivatization, separation and characterization of small molecules and polymeric macromolecules, primarily protein and peptide biomarkers. The integrated modular unit is also designed to perform metabolic or bioactivity studies.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: December 14, 2021
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventors: Norberto Guzman, Daniel E. Guzman
  • Publication number: 20210382003
    Abstract: A diagnostic and prognostic method and system for sequentially analyzing in a biological fluid or tissue extract the presence of an antigenic infectious agent, infectious organism or its toxic product; an antibody response to the antigenic infectious agent, infectious organism or its toxic product; one or more biomarkers formed during infection in response to a communicable disease; and one or more biomarkers to assess the severity of the disease and to monitor the effectiveness of drug therapy or vaccination.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 9, 2021
    Inventor: Norberto A. GUZMAN
  • Publication number: 20210260590
    Abstract: Micro-valve system includes two or more superimposed tubes and a pressing device for fluid control in miniaturized capillary connections. The micro-valve system and method of fabrication can be tailored to the requirements of a wide range of applications; composition, sturdiness and thickness of plastic tubes; and capable of been adapted to the resilient of mechanical pressure and the passing and transport of fluid types.
    Type: Application
    Filed: May 11, 2021
    Publication date: August 26, 2021
    Inventors: NORBERTO GUZMAN, Daniel E. GUZMAN
  • Publication number: 20190331637
    Abstract: An electrophoresis apparatus is generally disclosed for sequentially analyzing a single sample or multiple samples having one or more analytes in high or low concentrations. The apparatus comprises a relatively large-bore transport capillary which intersects with a plurality of small-bore separation capillaries and includes a valve system. Analyte concentrators, having antibody-specific (or related affinity) chemistries, are stationed at the respective intersections of the transport capillary and separation capillaries to bind one or more analytes of interest. The apparatus allows the performance of two or more dimensions for the optimal separation of analytes. The apparatus may also include a plurality of valves surrounding each of the analyte concentrators to localize each of the concentrators to improve the binding of one or more analytes of interest.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 31, 2019
    Inventor: NORBERTO A. GUZMAN
  • Patent number: 10408789
    Abstract: An electrophoresis apparatus is generally disclosed for sequentially analyzing a single sample or multiple samples having one or more analytes in high or low concentrations. The apparatus comprises a relatively large-bore transport capillary which intersects with a plurality of small-bore separation capillaries and includes a valve system. Analyte concentrators, having antibody-specific (or related affinity) chemistries, are stationed at the respective intersections of the transport capillary and separation capillaries to bind one or more analytes of interest. The apparatus allows the performance of two or more dimensions for the optimal separation of analytes. The apparatus may also include a plurality of valves surrounding each of the analyte concentrators to localize each of the concentrators to improve the binding of one or more analytes of interest.
    Type: Grant
    Filed: September 28, 2015
    Date of Patent: September 10, 2019
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventor: Norberto A. Guzman
  • Publication number: 20180280972
    Abstract: The present invention relates to an immunoaffinity device for capturing, isolating and purifying one or more analytes of interest present at high or low concentration in simple or complex matrices. The device is designed as an integrated modular unit that includes one or more analyte concentrator-microreactor devices anchored into a T-shaped support box, which is built-in or connected to a interchangeable cartridge-cassette of a capillary electrophoresis or liquid chromatography apparatus for the isolation, enrichment, derivatization, separation and characterization of small molecules and polymeric macromolecules, primarily protein and peptide biomarkers. The integrated modular unit is also designed to perform metabolic or bioactivity studies.
    Type: Application
    Filed: March 28, 2018
    Publication date: October 4, 2018
    Inventors: Norberto GUZMAN, Daniel E. GUZMAN
  • Patent number: 9696299
    Abstract: The integrated modular and interchangeable unit of the present invention comprises an analyte concentrator-microreactor (ACM) device having four entrance-exit ports identified as connection areas to a transport capillary for sample and buffer introduction, and to a separation capillary of a cartridge-cassette filled with an appropriate separation fluid for optimal separation of the analytes of interest. Affinity ligand groups are immobilized to microstructures contained within the main inner cavity or channel of the device or directly to the wall of the main inner channel for capturing one or more analytes. The inlet and outlet ends of the transport capillary are connected through a parallel design option to the analyte concentrator-microreactor (ACM) device to facilitate the path of sample and buffers through the inner cavity or channel of the analyte concentrator-microreactor (ACM) device.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: July 4, 2017
    Inventor: Norberto Guzman
  • Patent number: 9482602
    Abstract: The present invention relates to an immunoaffinity device for capturing one or more analytes present at high or low concentrations in simple or complex matrices. The device is designed as an integrated modular unit and connected to capillary electrophoresis or liquid chromatography for the isolation, enrichment, separation and identification of polymeric macromolecules, primarily protein biomarkers. The integrated modular unit includes an analyte-concentrator-microreaction device connected to a modified cartridge-cassette.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: November 1, 2016
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventor: Norberto A. Guzman
  • Publication number: 20160123925
    Abstract: An electrophoresis apparatus is generally disclosed for sequentially analyzing a single sample or multiple samples having one or more analytes in high or low concentrations. The apparatus comprises a relatively large-bore transport capillary which intersects with a plurality of small-bore separation capillaries and includes a valve system. Analyte concentrators, having antibody-specific (or related affinity) chemistries, are stationed at the respective intersections of the transport capillary and separation capillaries to bind one or more analytes of interest. The apparatus allows the performance of two or more dimensions for the optimal separation of analytes. The apparatus may also include a plurality of valves surrounding each of the analyte concentrators to localize each of the concentrators to improve the binding of one or more analytes of interest.
    Type: Application
    Filed: September 28, 2015
    Publication date: May 5, 2016
    Inventor: Norberto A. GUZMAN
  • Patent number: 9146234
    Abstract: A disease detection system which includes an electrophoresis apparatus and a biomarker detector. The apparatus includes: (a) a transport passage; (b) a plurality of separation passages, each of the separation passages having an overlapping portion that overlaps the transport passage; and (c) a different biomarker concentrator in each of the overlapping portions and which concentrates at least one different biomarker from a specimen from an animal introduced into the transport passage. A plurality of the different biomarkers is associated with at least one predetermined disease, such as diabetes, heart disease or cancer. The detector detects the presence of the different biomarkers which were concentrated by the biomarker concentrators and delivered to the biomarker detector via the separation passages. First and second sets of the biomarker concentrators can be associated with respective first and second predetermined diseases and the user can determine which set will be used in each procedure.
    Type: Grant
    Filed: February 26, 2010
    Date of Patent: September 29, 2015
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventor: Norberto A. Guzman
  • Patent number: D857231
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: August 20, 2019
    Assignee: PRINCETON BIOCHEMICALS, INC.
    Inventors: Norberto Guzman, Daniel E. Guzman
  • Patent number: D919833
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: May 18, 2021
    Inventors: Norberto Guzman, Daniel E. Guzman
  • Patent number: D923817
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: June 29, 2021
    Assignee: PRINCETON BIOCHEMICALS, INC
    Inventors: Norberto Guzman, Daniel E. Guzman
  • Patent number: D970041
    Type: Grant
    Filed: February 4, 2021
    Date of Patent: November 15, 2022
    Inventors: Norberto Guzman, Daniel E. Guzman